Hodgkin Lymphoma Panel - Disclosures
|
Panel Member
|
Ranjana Advani MD |
|
Grant/Research Support
|
| BeiGene | Daiichi- Sankyo Co. | Genentech, Inc. | Merck & Co., Inc. | Millennium Pharmaceuticals, Inc. | Regeneron Pharmactcls | Roche Laboratories, Inc. | SeaGen |
|
Date Completed
|
07/29/2024 |
|
Panel Member
|
Philippe Armand MD, PhD |
|
Grant/Research Support
|
| Adaptive Biotechnologies | AstraZeneca Pharmaceuticals LP | Bristol Myers Squibb | Genentech, Inc. | IGM Biosciences | Kite Pharma | Merck & Co., Inc. |
|
Officer, Director or any other fiduciary role
|
| Tessa Therapeutics |
|
Date Completed
|
07/31/2024 |
|
Panel Member
|
Celeste Bello MD, MSPH |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Cecil Benitez MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Marian Birkeland PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Nicole Blankenhorn |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
David Bond MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Weina Chen MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Sheen Cherian MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Magdalena Czader MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Bouthaina Dabaja MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Megan Daly MD |
|
Grant/Research Support
|
| EMD Serono | Genentech, Inc. | Merck & Co., Inc. |
|
Date Completed
|
04/15/2025 |
|
Panel Member
|
Sarah DeVincenzo PharmD, BCPS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Zachary Frosch MD, MSHP |
|
Grant/Research Support
|
| AbbVie, Inc. | Acerta Pharma | Amgen Inc. | Antigenics Inc. | AstraZeneca Pharmaceuticals LP | Genmab | Merck & Co., Inc. | Roche Laboratories, Inc. | sanofi-aventis U.S. |
|
Date Completed
|
07/25/2024 |
|
Panel Member
|
Leo Gordon MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Kristina Gregory MSN, RN |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Evelyn Handel PharmD, BCOP, BCPS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Neil Hansen MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Alex Herrera MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Erin Hesler |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Ephraim Hochberg MD |
|
Equity Interest/Stock Options
|
| Leuko - hardware device manufacturer, no marketed products |
|
Date Completed
|
07/30/2024 |
|
Panel Member
|
Richard Hoppe MD |
|
Equity Interest/Stock Options
|
| General Electric | Johnson & Johnson | Pfizer Inc. |
|
Date Completed
|
07/29/2024 |
|
Panel Member
|
Iris Isufi MD |
|
Product/Speakers Bureau
|
| Kite Pharma |
|
Date Completed
|
09/11/2024 |
|
Panel Member
|
Patrick Johnston MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Madeline Joyce BSN, RN, OCN |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Kara Kelly MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Christopher Kelsey MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Vaishalee Kenkre MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Justin Kline MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Ryan Lynch MD |
|
Grant/Research Support
|
| Bayer HealthCare | Cyteir | Incyte Corporation | Janssen Pharmaceutica Products, LP | Merck & Co., Inc. | Pfizer Inc. | Rapt | TG Therapeutics |
|
Date Completed
|
07/30/2024 |
|
Panel Member
|
Jonathan McConathy MD, PhD |
|
Grant/Research Support
|
| Cytosite Biopharma | Eli Lilly and Company | Novartis Pharmaceuticals Corporation |
|
Date Completed
|
09/20/2024 |
|
Panel Member
|
Sarah Montgomery |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
David Morgan MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Alex Niu MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Aaron Oliver PharmD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Suman Paul PhD, MBBS |
|
Equity Interest/Stock Options
|
| Gilead Sciences, Inc. | TBD pharma |
|
Date Completed
|
03/26/2025 |
|
Panel Member
|
Donna Powell DHSc, CMD, RT(T) |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Rachel Rabinovitch MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Ali Salavati MD, MPH |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Dahlia Sano MBChB |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Harsh Shah DO |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Michael Spinner MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Katie Stehman MMS, PA-C |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Jakub Svoboda MD |
|
Grant/Research Support
|
| Adaptive | AstraZeneca Pharmaceuticals LP | Bristol Myers Squibb | Genmab | Incyte Corporation | Kite Pharma | Merck & Co., Inc. | Pharmacyclics | TG |
|
Date Completed
|
09/24/2024 |
|
Panel Member
|
Erin Vidic |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Jane Winter MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Joachim Yahalom MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Joanna Yang MD, MPH |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
